Addressing Social Determinants of Health in Marginalized and Unrepresented Communities with Kistein Monkhouse Patient Orator TRANSCRIPT
Download PDFMay 12, 2021
Kistein Monkhouse is the Founder of Patient Orator, a start-up that is focused on providing services to racial and ethnic minorities, lower-income communities, the elderly, LGBT communities and other people who are marginalized or underrepresented in receiving healthcare.
With a focus on systemic racism and implicit...
May 12, 2021
Kistein Monkhouse is the Founder of Patient Orator, a start-up that is focused on providing services to racial and ethnic minorities, lower-income communities, the elderly, LGBT communities and other people who are marginalized or underrepresented in receiving healthcare.
With a focus on systemic racism and implicit...
Infusing Rhenium NanoLiposomes into Glioblastoma Showing High Efficacy Eradicating These Brain Tumors with Dr. Marc Hedrick PLUS Therapeutics TRANSCRIPT
Download PDFMay 10, 2021
Dr. Marc Hedrick, President and CEO, PLUS Therapeutics describes the challenges of fighting brain cancers like glioblastoma. The PLUS lead investigational asset Rhenium NanoLiposome (RNL) delivers radiation directly to the tumor using a method called Convection Enhanced Delivery. This approach allows the neurosurgeon...
May 10, 2021
Dr. Marc Hedrick, President and CEO, PLUS Therapeutics describes the challenges of fighting brain cancers like glioblastoma. The PLUS lead investigational asset Rhenium NanoLiposome (RNL) delivers radiation directly to the tumor using a method called Convection Enhanced Delivery. This approach allows the neurosurgeon...
Treating Hypersensitivity Disorders by Focusing on Specific Sodium Channel with John Mulcahy SiteOne Therapeutics TRANSCRIPT
Download PDFMay 6, 2021
John Mulcahy PhD, President and CEO, SiteOne Therapeutics talks about broadening their pipeline from acute pain to hypersensitivity disorders like chronic cough and itching. Approach is to inhibit voltage-gated subtype sodium channel Nav1.7, a genetically validated target for pain. Stopping the pain signal in the...